TY - JOUR AB - Following the publication of the above paper, an interested reader drew to the authors’ attention that, in Fig. 5 on p. 1637, the data panel selected to represent the ‘Ishikawa/+BMI‑1 siRNA/Invasion’ experiment in Fig. 5A appeared to overlap with the data shown for the ‘JEC/+BMI‑1 siRNA/Migration’ panel in Fig. 5C, such that they were potentially derived from the same original source. The authors have re‑examined their original data, and realize that the data panel selected for the ‘Ishikawa/+BMI‑1 siRNA/Invasion’ experiment in Fig. 5A was inadvertently selected incorrectly. The corrected version of Fig. 5, showing the correct data for the ‘Ishikawa/+BMI‑1 siRNA/Invasion’ experiment in Fig. 5A, is shown below. Note that this error did not affect the overall conclusions reported in the study. The authors are grateful to the Editor of Oncology Reports for granting them the opportunity to publish this Corrigendum; furthermore, they apologize for any inconvenience caused to the readership of the Journal. [Oncology Reports 43: 1630‑1640, 2020; DOI: 10.3892/or.2020.7539] AD - Department of Pathology, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, Shandong 264100, P.R. China Department of Obstetrics and Gynecology, First Affiliated Hospital of Shihezi University, Shihezi, Xinjiang 832001, P.R. China Department of Oncology, People's Hospital of Haiyang, Haiyang, Shandong 265100, P.R. China Department of Physical Examination, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, Shandong 264100, P.R. China Department of Obstetrics and Gynecology, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, Shandong 264100, P.R. China AU - Yu,Jing AU - Chen,Ling AU - Bao,Zhenhua AU - Liu,Ying AU - Liu,Guohong AU - Li,Fengling AU - Li,Lianqin DA - 2022/08/01 DO - 10.3892/or.2022.8352 IS - 2 JO - Oncol Rep KW - B‑lymphoma Mo‑MLV insertion region 1 endometrial adenocarcinoma clinicopathological parameters epithelial‑mesenchymal transition PY - 2022 SN - 1021-335X 1791-2431 SP - 141 ST - [Corrigendum] BMI‑1 promotes invasion and metastasis in endometrial adenocarcinoma and is a poor prognostic factor T2 - Oncology Reports TI - [Corrigendum] BMI‑1 promotes invasion and metastasis in endometrial adenocarcinoma and is a poor prognostic factor UR - https://doi.org/10.3892/or.2022.8352 VL - 48 ER -